FDA-Approved Pharmaceutical Supply – Loratadine Tablets

The contract pertains to the supply of 98,000 bulk tablets of Loratadine, identified by NSN 6505015785988 and NDC 00904-6852-89, manufactured in full compliance with current Good Manufacturing Practices and all applicable federal pharmaceutical standards. The product is intended for distribution under the auspices of the Defense Logistics Agency, a component of the Department of Defense, and will be delivered under the subcontract vehicle SPE2DP26F8705, with the original contract number SPE2DX25D9900. The manufacturing process and final product must meet rigorous quality control benchmarks to ensure safety, efficacy, and regulatory adherence across all stages of production. The solicitation was posted on August 5, 2026, and falls under NAICS code 325412, which classifies the industry as Pharmaceutical Preparation Manufacturing. There is no specific set-aside designation or small business preference indicated, and the place of performance and point of contact details are not provided. The contractual obligation centers strictly on the provision of a large-volume, standardized pharmaceutical product for federal use, with no additional services or ancillary support required beyond the delivery of compliant bulk tablets. All units must be traceable, properly labeled, and packaged to meet military and federal logistics specifications.